Monday, August 22, 2022

Medicare sticks to coverage limits on Biogen's Aduhelm - Fierce Pharma

UPDATE: Bluebird bio's $2.8M gene therapy Zynteglo wins FDA backing. Will its US launch take flight? Aug 17, 2022 01:55pm.
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercepharma.com/pharma/cms-sticks-its-guns-will-limit-coverage-biogens-aduhelm-clinical-trials&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw0vpDx70KplNmadJvPIlpRv

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...